
Narayan Ayupharma Private Limited
Founded in 2009 and headquartered in Gujarat, India.
Founded in 2009 and headquartered in Gujarat, India.
Gandhi Nagar, Gujarat, India
+91-XXXXXXXXXX
U24230GJ2009PTC056231
056231
Private Limited Indian Non-Government Company
27 Feb 2009
30 Sep 2018
31 Mar 2018
Unlisted
Roc Ahmedabad
Name | Designation | Appointment Date | Status |
---|---|---|---|
Mahipal Kumpavat ![]() | Director | 27-Feb-2009 | Current |
Jitendra Barot ![]() | Additional Director | 01-Apr-2013 | Current |
Narayan Ayupharma Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
In 2017, Narayan Ayupharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Mahipal Kumpavat is a mutual person
Mahipal Kumpavat is a mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Narayan Ayupharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Narayan Ayupharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Narayan Ayupharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Narayan Ayupharma Private Limited last Annual general meeting of members was held on 30 Sep 2018 as per latest MCA records.
Narayan Ayupharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Ahmedabad.
Jitendra Balkrishn Barot was appointed as a Additional Director was appointed as a Additional Director on 01 Apr 2013 & has been associated with this company since 12 years 17 days .
Mahipal Vijaysinh Kumpavat was appointed as a Director was appointed as a Director on 27 Feb 2009 & has been associated with this company since 16 years 1 month .
Narayan Ayupharma Private Limited was registered on 27 Feb 2009 with Roc Ahmedabad & aged 16 years 1 month as per MCA records.
Narayan Ayupharma Private Limited was incorporated on 27 Feb 2009.
The authorized share capital of Narayan Ayupharma Private Limited is ₹ 1.50 M and paid-up capital is ₹ 1.45 M.
Currently 2 directors are associated with Narayan Ayupharma Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Narayan Ayupharma Private Limited is 25 Satyam Raw House, A'Bad-Mehsana Highway Nr. Gayatri Mandir India, Kalol, Gujarat, 382721.
The corporate identification number (CIN) of Narayan Ayupharma Private Limited is U24230GJ2009PTC056231 and the company number is 056231 as per Ministry of Corporate Affairs (MCA).
The most recent Balance Sheet for Narayan Ayupharma Private Limited was filed with the ROC on 31 Mar 2018.
Search company & director profiles for free and gain access to critical business data.
VK